EOS imaging SA designs, develops, markets, and sells medical imaging devices for osteo-articular conditions and orthopedics, and related applications.
Limited growth with imperfect balance sheet.
Share Price & News
How has EOS imaging's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: EOSI's share price has been volatile over the past 3 months.
7 Day Return
FR Medical Equipment
1 Year Return
FR Medical Equipment
Return vs Industry: EOSI underperformed the French Medical Equipment industry which returned 47.4% over the past year.
Return vs Market: EOSI underperformed the French Market which returned -3.8% over the past year.
Price Volatility Vs. Market
How volatile is EOS imaging's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 months ago | Simply Wall StHere's Why EOS imaging (EPA:EOSI) Can Afford Some Debt
5 months ago | Simply Wall StSome EOS imaging (EPA:EOSI) Shareholders Have Copped A Big 55% Share Price Drop
6 months ago | Simply Wall StCould The EOS imaging SA (EPA:EOSI) Ownership Structure Tell Us Something Useful?
Is EOS imaging undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate EOSI's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate EOSI's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: EOSI is unprofitable, so we can't compare its PE Ratio to the Medical Equipment industry average.
PE vs Market: EOSI is unprofitable, so we can't compare its PE Ratio to the French market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate EOSI's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: EOSI is overvalued based on its PB Ratio (2.9x) compared to the FR Medical Equipment industry average (2.6x).
How is EOS imaging forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EOSI is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: EOSI is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: EOSI is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: EOSI's revenue (31.8% per year) is forecast to grow faster than the French market (3.9% per year).
High Growth Revenue: EOSI's revenue (31.8% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EOSI's Return on Equity is forecast to be high in 3 years time
How has EOS imaging performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: EOSI is currently unprofitable.
Growing Profit Margin: EOSI is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: EOSI is unprofitable, and losses have increased over the past 5 years at a rate of -28.2% per year.
Accelerating Growth: Unable to compare EOSI's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: EOSI is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (-1.8%).
Return on Equity
High ROE: EOSI has a negative Return on Equity (-152.58%), as it is currently unprofitable.
How is EOS imaging's financial position?
Financial Position Analysis
Short Term Liabilities: EOSI's short term assets (€44.6M) exceed its short term liabilities (€23.1M).
Long Term Liabilities: EOSI's short term assets (€44.6M) exceed its long term liabilities (€29.7M).
Debt to Equity History and Analysis
Debt Level: EOSI's debt to equity ratio (218.4%) is considered high.
Reducing Debt: EOSI's debt to equity ratio has increased from 14.1% to 218.4% over the past 5 years.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EOSI has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: EOSI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 5.9% each year
What is EOS imaging's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate EOSI's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate EOSI's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if EOSI's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if EOSI's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of EOSI's dividend in 3 years as they are not forecast to pay a notable one for the French market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Mike Lobinsky is Chief Executive Officer of EOS imaging SA since January 1, 2019 and serves as its Director. He was President of North America at EOS imaging SA since joining in August 2017 until Decem ...
|CEO & Director||1.42yrs||no data||no data|
|Chief Financial Officer||1.58yrs||no data||no data|
|Chief Operating Officer||2.67yrs||no data||no data|
|Vice President of Global Marketing||0.42yr||no data||no data|
|Chief Medical Officer||4.83yrs||no data||no data|
|Field Maintenance Director||no data||no data||no data|
Experienced Management: EOSI's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
|CEO & Director||1.42yrs||no data||no data|
|Director||no data||€682.70k||1.41% €489.3k|
|Chairman of the Board||4.92yrs||€65.00k||0.013% €4.6k|
|Independent Director||8yrs||€30.00k||no data|
|Director||8.5yrs||no data||no data|
|Director||1.5yrs||no data||no data|
Experienced Board: EOSI's board of directors are considered experienced (6.5 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: EOSI insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
EOS imaging SA's company bio, employee growth, exchange listings and data sources
- Name: EOS imaging SA
- Ticker: EOSI
- Exchange: ENXTPA
- Founded: 1989
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: €34.765m
- Shares outstanding: 26.50m
- Website: https://www.eos-imaging.com
Number of Employees
- EOS imaging SA
- 10 rue Mercœur
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|EOSI||ENXTPA (Euronext Paris)||Yes||Common Stock||FR||EUR||Feb 2012|
|0QAR||LSE (London Stock Exchange)||Yes||Common Stock||GB||EUR||Feb 2012|
|EOSIP||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Common Stock||GB||EUR||Feb 2012|
|EOSG.F||OTCPK (Pink Sheets LLC)||Yes||Common Stock||US||USD||Feb 2012|
EOS imaging SA designs, develops, markets, and sells medical imaging devices for osteo-articular conditions and orthopedics, and related applications. It offers EOS, an imaging system that provides low dose, full body, and stereo-radiographic images of patient in a functional position; EOSedge, an X-ray system that provides images quality for patients; sterEOS, a 3D modeling workstation that analyzes frontal and lateral EOS images which are captured simultaneously and registered to generate precise, patient-specific, and 3D models of the spine and/or lower limbs from weight-bearing, low dose, or Micro Dose EOS exams; and EOSapps, an online 3D surgical planning solutions based on unbiased, weight-bearing EOS images, and an accurate 2D/3D patient-specific data set. The company also provides 3D surgical planning software and patient-specific instruments for hip and knee arthroplasties. It sells its products in Europe, the Middle East, Africa, North Africa, and the Asia-Pacific. The company was formerly known as biospace med and changed its name to EOS Imaging SA in 2010. EOS imaging SA was founded in 1989 and is headquartered in Paris, France.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/06/05 23:16|
|End of Day Share Price||2020/06/05 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.